Infinimmune Launches GLIMPSE-1 AI Model Trained Exclusively on Human Antibody Sequences for Advanced Therapeutic Engineering
Infinimmune, a biotechnology company pioneering human-first antibody discovery and design, today announced the launch of GLIMPSE-1, a protein language model trained solely on native human antibody sequences. Developed using millions of paired heavy and light chains from human memory B cells, GLIMPSE-1 represents a new paradigm for therapeutic antibody engineering that applies the design principles of the human adaptive immune system.
Infinimmune published results in a new bioRxiv preprint, demonstrating that GLIMPSE-1 can humanize clinical antibodies, engineer for affinity and developability parameters, and generate highly divergent functional variants, all through in silico design guided by the biology of the human adaptive immune system.
'Fully human antibodies carry the evolutionary fingerprints of the human immune system, optimized over millions of years,' said Wyatt McDonnell, Ph.D., Co-Founder and CEO, Infinimmune. 'With GLIMPSE-1, we can decode and encode that logic directly from immune repertoires to discover and design better, safer biologics from day one. This approach complements the FDA's recent focus on assessing human-relevant methods for therapeutic development, which could ultimately benefit patients through more comprehensive safety assessment. We believe models like GLIMPSE-1 will remain essential in the discovery and development of modern antibody medicines.'
GLIMPSE-1 was developed as a core component of Infinimmune's therapeutic development capabilities, strengthening the company's pipeline of antibody drug candidates. The model was trained using a large, diverse dataset with proprietary sequences from Infinimmune's Complete Human® and Anthrobody® technologies, which source antibodies directly from native human repertoires, allowing it to learn the biological and functional constraints of human immunity.
Key results from the preprint include:
GLIMPSE-1 operates entirely in human antibody sequence space, predicting viable antibody variants without 3D structure modeling, energy calculations, or experimental screening beforehand. The resulting antibodies maintain essential functional properties and characteristics consistent with clinically approved monoclonal antibodies, all guided by patterns learned from human immune systems.
The development of GLIMPSE-1 aligns with recent FDA initiatives exploring human-relevant methodologies for therapeutic development. The FDA's roadmap for integrating New Approach Methodologies (NAMs) identifies monoclonal antibodies as an initial focus area, creating an environment where human-first models like GLIMPSE-1 may provide valuable complementary insights.
Infinimmune has successfully integrated GLIMPSE-1 into its therapeutic antibody development pipeline, where the model has significantly contributed to the engineering and optimization of the company's lead programs. The company is currently exploring strategic partnerships with pharmaceutical and biotechnology companies to apply GLIMPSE-1's capabilities to partner's therapeutic programs.
About Infinimmune
Infinimmune is a biotechnology company pioneering a novel approach to antibody drug discovery and development. Founded by a world-class, multidisciplinary team of scientists and technologists, Infinimmune is reinventing antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. These truly human antibodies are designed to drug new and existing targets with improved safety and efficacy. Infinimmune is building its own pipeline of drug candidates and partnering with pharmaceutical companies to advance their antibody programs, fill their pipelines, and reach new patients and new indications. To learn more, visit infinimmune.com and follow us on LinkedIn and @infinimmune.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250611619715/en/
CONTACT: Media
Kimberly Ha
KKH Advisors
917-291-5744
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: RESEARCH TECHNOLOGY GENETICS SOFTWARE BIOTECHNOLOGY PHARMACEUTICAL HEALTH SCIENCE ARTIFICIAL INTELLIGENCE OTHER SCIENCE
SOURCE: Infinimmune
Copyright Business Wire 2025.
PUB: 06/12/2025 08:07 AM/DISC: 06/12/2025 08:05 AM
http://www.businesswire.com/news/home/20250611619715/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
33 minutes ago
- Business Wire
EveryLife Mobilizes Urgent Relief Efforts in Response to Devastating Texas Floods
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--In response to the devastating floods currently impacting communities across Texas, EveryLife, America's fastest-growing pro-life diaper company, is mobilizing immediate support to help families in need. Through its Buy For a Cause initiative, EveryLife is allocating all Buy For a Cause diaper and wipe bundles to those directly affected by the disaster. 'We are heartbroken by the destruction caused by the Texas floods,' said Sarah Gabel Seifert, President and Co-Founder of EveryLife. 'As a company built to serve families, it's our mission and responsibility to step in during moments of crisis. In times like these, families need to know they're not alone. Our hope is that through something as simple as a box of diapers and wipes, we can remind parents that they are supported and cared for.' Joining forces with EveryLife's trusted partners CityServe and Convoy of Hope, these critical essentials will be delivered to families experiencing displacement, loss and hardship. For just $50, supporters across the country can join EveryLife's efforts by providing a one-month supply of diapers and wipes to a Texas family in need. Bundles can be donated at EveryLife has previously responded to national emergencies including hurricanes and wildfires and has partnered with trusted organizations to meet urgent needs by providing millions of diapers and wipes wherever families are hurting most. For more information on EveryLife, please visit: About EveryLife: EveryLife is America's fastest-growing diaper brand and the first and only pro-life diaper brand. As a wholly owned subsidiary of PublicSquare (NYSE: PSQH), the premium direct-to-consumer diaper brand delivers high-performing diapers, wipes, and baby essentials directly to families nationwide. Committed to a mission beyond just products, EveryLife actively supports life-affirming organizations by providing essential baby items to crisis pregnancy centers in urgent need. Since launching in July 2023, EveryLife has become a trusted choice for parents who seek both premium quality and purpose-driven impact. For more information, visit
Time Business News
an hour ago
- Time Business News
Brighten Your Skin Safely: Why Hydroquinone 4% Cream Remains the Gold Standard for Hyperpigmentation
In the world of skincare, achieving a flawless, even-toned complexion is often a top goal. Whether you're dealing with dark spots, melasma, age spots, or acne scars, hydroquinone cream 4 percent remains one of the most trusted and dermatologist-recommended treatments for fading hyperpigmentation. If you're looking to understand how it works, what results to expect, and where to buy hydroquinone 4% cream online, this in-depth guide is for you. What is Hydroquinone 4% Cream? Hydroquinone is a skin-lightening agent that works by inhibiting tyrosinase, an enzyme responsible for the production of melanin (the pigment that gives skin its color). At a concentration of 4%, it's considered the most effective over-the-counter strength for treating moderate to severe hyperpigmentation. Common skin concerns treated with hydroquinone 4% cream include: Melasma Age spots Post-inflammatory hyperpigmentation (PIH) Acne scarring Freckles and sunspots This strength is typically recommended for individuals who have previously used lighter concentrations (like 2%) and are looking for more dramatic, faster results. Benefits of Hydroquinone 4% Cream The advantages of using hydroquinone cream at 4% strength are clear and well-documented: Rapid Fading of Dark Spots: Noticeable improvement in 4–6 weeks of consistent use. Noticeable improvement in 4–6 weeks of consistent use. Evens Out Skin Tone: Helps reduce blotchiness and patchiness. Helps reduce blotchiness and patchiness. Minimal Downtime: Non-invasive and easy to apply at home. Non-invasive and easy to apply at home. Dermatologist Recommended: A top choice in skin clinics for decades. People often search for terms like 'hydroquinone 4 cream results' or 'hydroquinone 4 cream before and after pictures' to see real-life transformations. A consistent regimen, combined with sun protection, makes all the difference. How to Use Hydroquinone 4% Cream Correctly To ensure maximum benefits while avoiding irritation or side effects, follow these steps: Cleanse: Wash your face with a mild, non-irritating cleanser. Apply Thin Layer: Use a small amount of hydroquinone cream on the affected area only. Moisturize: Wait a few minutes and apply a hydrating, non-comedogenic moisturizer. Sunscreen is Non-Negotiable: Always use broad-spectrum SPF 30 or higher during the day. Use Once Daily: Usually applied at night, unless otherwise instructed by a healthcare provider. Avoid using with products that contain benzoyl peroxide, AHAs, or vitamin C initially, as they may cause irritation. Hydroquinone Cream 4% vs. Other Bleaching Creams Some people wonder whether 'hydroquinone bleaching cream' is safe or if they should opt for natural alternatives. While hydroquinone is technically a bleaching agent, it is FDA-approved and widely used in clinical dermatology. Compared to natural alternatives, hydroquinone: Works faster and more effectively Is supported by decades of clinical studies Targets pigment directly at the source (melanin production) It's important to follow usage instructions and take breaks (often 3 months on, 1 month off) to prevent overuse. Understanding Hydroquinone 4 Cream Price and Accessibility The hydroquinone 4 cream price can vary significantly depending on the brand and where you purchase it. In the U.S., prescription formulations may cost $60–$100 or more. Fortunately, you can buy hydroquinone online from trusted international pharmacies like OKDERMO at a much more affordable rate—without a prescription in many regions. This makes it easier to access professional-grade skincare without paying a premium or visiting a dermatologist. Where to Buy Hydroquinone 4 Cream Online Safely While some turn to large marketplaces and search 'hydroquinone 4 cream Amazon,' it's important to be cautious. Not all listings guarantee authenticity or proper storage. Buying from a specialty skincare provider like OKDERMO ensures: Pharmaceutical-grade product Proper packaging and shipping Trusted customer service and global delivery OKDERMO carries Melalite 4 Cream, a well-known brand that delivers powerful skin-lightening results using 4% hydroquinone. Before and After Expectations Seeing hydroquinone 4 cream before and after pictures can be highly motivating. Most users report visible changes within 4 to 6 weeks, with optimal results seen after 2 to 3 months of regular use. Note: Hydroquinone results are not immediate. It requires consistent application, sun protection, and patience. Once the desired skin tone is achieved, dermatologists typically recommend discontinuing use or switching to maintenance products to avoid over-depigmentation. Safety and Precautions While hydroquinone is safe for most users, it's important to use it correctly and monitor your skin's reaction: Do not use on broken or inflamed skin. Avoid long-term use without breaks. A 3-month cycle is often recommended. A 3-month cycle is often recommended. Consult a dermatologist if you experience severe redness, burning, or unusual pigmentation changes. Always do a patch test before applying it to larger areas. Final Thoughts If you're seeking a reliable and effective solution to dark spots and uneven skin tone, hydroquinone 4% cream stands out as the gold standard. Backed by decades of medical use and clinical evidence, it delivers visible results in a matter of weeks. Rather than risking unknown sellers or overpriced prescriptions, buy directly from a trusted source. OKDERMO's Melalite 4 Cream offers pharmaceutical-grade strength and proven outcomes at an affordable price—no prescription required. TIME BUSINESS NEWS
Bloomberg
2 hours ago
- Bloomberg
When an HIV Scientific Breakthrough Isn't Enough
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences' lenacapavir is so effective that global health leaders had started to cautiously talk about the end of an epidemic that continues to kill more than 600,000 people each year. We should be celebrating its arrival.
